Titled "CBD as a cure-all? The impacts of state-level legalization of prescription cannabidiol (CBD) on opioid prescriptions," delves into the effects of state-level legalization of CBD acceess on opioid prescribing rates.

See Also: Fentanyl Fuels Ongoing US Drug Overdose Crisis: Over 109,000 Deaths Lost in 12 Months

Key Findings

CBD Legalization Alone's Impact

"We investigate the impacts of state legalization of products containing cannabidiol (CBD), a non-psychoactive alternative to marijuana, on opioid prescribing rates," begins the study.

It highlights that while research has suggested that legalized medical marijuana may reduce opioid prescriptions, there has been no empirical link between CBD and opioids established.

The study was published in the Southern Economic Journal by economists at …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.